-
CGRP/SP–Piezo2 Axis in Trigeminal Neuralgia
2026-08-23
Liao et al. connect trigeminal root compression with a Ca2+-dependent neuroinflammatory circuit involving CGRP, substance P, and the mechanosensitive channel Piezo2. Their rat and cell-based experiments suggest that a trigeminal ganglion–Merkel cell feedback loop contributes to mechanical allodynia and provides a mechanistic framework for studying persistent touch-evoked pain.
-
Lamotrigine: Mapping Mechanism Across Assays
2026-08-22
Lamotrigine research often focuses on neuronal sodium channels, but its assay interpretation can extend to serotonin pathways, cardiac electrophysiology, and CYP19 activity. This guide develops an evidence-based framework for selecting orthogonal endpoints and avoiding overinterpretation.
-
YC-1 Assay Design for Hypoxia Research
2026-08-22
A scenario-driven guide to using YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, SKU B7641, in viability, proliferation, and hypoxia-focused cancer research. It covers solvent control, dose planning, orthogonal readouts, interpretation, and practical product-selection criteria.
-
S63845 MCL1 Inhibitor Workflow Guide
2026-08-21
Build cleaner mitochondrial apoptosis experiments with a selective MCL1 inhibitor, from DMSO stock preparation through orthogonal cell-death readouts. This guide also shows how S63845 can be positioned in hematological cancer research and mechanistically informed combination studies.
-
Procainamide Hydrochloride Research Guide
2026-08-20
Procainamide Hydrochloride is a cardiac sodium channel blocker used in cardiac electrophysiology research and mechanistic cell studies. Product specifications and a peer-reviewed cisplatin-liposome study support distinct, assay-dependent applications rather than a single universal mechanism.
-
Hexamethonium Bromide in Autonomic Research
2026-08-20
Hexamethonium Bromide provides a practical way to test how autonomic ganglionic transmission contributes to blood pressure, heart-rate, and baroreflex phenotypes. This guide translates sex-specific angiotensin II hypertension findings into reproducible workflows for telemetry, ex vivo assays, and neuronal signaling pathway research.
-
Sex Differences in Ang II-Induced Hypertension
2026-08-19
This study used conscious-mouse telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces substantially stronger hypertension in males than females. Its findings connect sex-dependent blood pressure responses with altered baroreflex control and a greater autonomic contribution in male mice, providing a useful framework for mechanistic hypertension research.
-
GSK126 EZH2 Inhibitor: Mechanism and Use
2026-08-19
GSK126 is a potent EZH2 inhibitor that suppresses PRC2-dependent H3K27me3 and supports research into epigenetic gene silencing. Its strongest applications include cancer epigenetics research, lymphoma with EZH2 mutations, and mechanistic studies that separate EZH2 catalytic activity from noncatalytic functions.
-
Lamotrigine in BBB and Sodium Channel Research
2026-08-18
Lamotrigine supports a practical bridge between sodium-channel pharmacology, serotonin pathway assays, and high-throughput blood–brain barrier screening. This workflow shows how to control solubility, distinguish passive transport from efflux or lysosomal trapping, and extend findings cautiously into epilepsy and cardiac research.
-
Indole-3-pyruvic acid: Applied Bench Workflows
2026-08-17
Indole-3-pyruvic acid supports two distinct research directions: probing TAA1-linked auxin control in plants and testing AhR, UHRF1, and AMPK biology in mammalian systems. This workflow-focused guide covers dosing, controls, cross-domain interpretation, and troubleshooting for more reproducible IPA experiments.
-
BODIPY 581/591 C11 for Lipid Peroxidation
2026-08-17
BODIPY 581/591 C11 converts membrane lipid oxidation into a measurable red-to-green fluorescence shift, enabling ratiometric analysis rather than relying on signal intensity alone. This practical guide shows how to apply it to endothelial ferroptosis, diabetic osteoporosis models, antioxidant capacity evaluation, and live-cell oxidative stress workflows.
-
Metabolism of Sumatriptan Revisited: CYP and MAO
2026-08-16
Pöstges and Lehr reassessed the accepted metabolic pathway of sumatriptan using recombinant human cytochrome P450 and monoamine oxidase enzymes with HPLC–MS analysis. Their results show that CYP-mediated N-demethylation can occur alongside MAO A-dependent oxidative deamination, revising the assumed order of biotransformation and improving interpretation of metabolite studies.
-
AG-120 (Ivosidenib) for IDH1 Mutant AML Research
2026-08-15
AG-120 (Ivosidenib) connects mutant IDH1 inhibition with measurable 2-hydroxyglutarate reduction and differentiation biology. This workflow-oriented guide shows how to evaluate metabolic response, erythropoietin-induced differentiation, CD44-linked resistance, and assay quality in IDH1-mutant leukemia models.
-
BHBA: A Metabolic Lever for Stroke Neuroprotection
2026-08-14
3-hydroxybutyrate (BHBA) offers translational researchers a way to test how ketone metabolism intersects with ferroptosis, neuronal survival, membrane biology, and chromatin regulation. Drawing on a stroke study of remote ischemic postconditioning, this article outlines how to use BHBA as a mechanistic probe while avoiding the common mistake of equating a direct metabolite add-back with whole-body ketosis.
-
UTP Solution for RNA Workflows and TRIM66 Studies
2026-08-14
A practical guide to using high-purity UTP in transcription, RNA amplification, siRNA precursor production, and nucleotide-linked metabolic assays. It also shows how RNA readouts can extend mechanistic studies of TRIM66-dependent olfactory receptor repression without overstating what the reference study directly demonstrated.